Phase 0 (C-enabling pipeline work) → Phase 1 (Paper C clinical validation) → Phase 2 (open-source release + Paper A), with Track 2 (clinical platform) as a contingent side track. Mirrors RESEARCH.md but for engineering scope rather than methodology.
